This analysis of cannabis stocks using Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (AEBITDA) is a factor contributing to the stocks ranked as best cannabis stocks in the Best Cannabis Stocks Analysis.
The following table shows the analysis based on quarterly AEBITDA starting Q1 2020 for the 16 stocks shortlisted in terms of quarterly revenue around or exceeding US$50 million. The table lists stocks in order of % quarters with positive AEBITDA, followed by highest total AEBITDA for the decade.
The main metric to look at is the number of quarters with positive AEBITDA. This is the factor incorporated into the methodology to rank the Best Cannabis Stocks analysis. Companies that consistently delivered positive AEBITDA were favorably ranked, while those with consistently negative AEBITDA were unfavorable ranked. The list is led by the three US MSOs with dedicated analysis pages in the STOCKS category, Trulieve Cannabis, Curaleaf Holdings, and Green Thumb Industries. The companies categorized as apriums (vertically integrated with retail and production), including several MSOs and High Tide, were favorable ranked in this methodology with multiple quarters will positive AEBITDA. Tilray and WM Technology were also favorable ranked. In contrast the Licensed Producers (plums) with consistently negative AEIBITDA quarters through the decade have been unfavorably ranked in this methodology. Points were assigned accordingly in the Best Cannabis Stocks analysis.
I am aware that AEBITDA is not a perfect metric, but it is an industry recognized metric that is worthy of analysis. Several analysts at reputed Financial Institutions use AEIBITDA to compute price targets for stocks in the cannabis sector.
Some investors prefer net income as a metric, but that would be impacted if a company is reinvesting in growth, as was with the case with Amazon during the first decade of the century. For this blog, AEBITDA was used as it provides a good way to identify strong performing companies, without penalizing those that reinvest funds for growth.
FABCBD Sleep Gummies for nighttime use which has CBD along with natural ingredients like Ashwagandha, a herb used in Ayurveda, the ancient plant medicine of India
A point to note is that there were instances where the quarterly numbers were inconsistent in the news releases, especially when a company restated some numbers in future quarters. I have done my best to use the most accurate and recently available quarterly AEBITDA numbers. But the numbers do serve the purpose of presenting the big picture on a balanced ranking on Cannabis stocks.
This analysis and the tables included will be updated on a regular basis and the relative rankings are expected to change based on AEBITDA numbers reported. The ANALYSIS category of this blog has the other analyses incorporated into the Best Cannabis Stocks analysis.
If you find any article here worth sharing, please share via the social media share options. If you are interested in connecting, you can do so on Twitter (@numbersnarrati) and Stocktwits (@AdastraYOLO). To support, please check out the affiliate links (especially CBD and other cannabinoid products) or become a Patron via the Numbers Narrative Patreon Page.
Disclaimer: All content and analysis on this Blog/website is information shared for educational and entertainment purposes only. The content creator(s) of this Blog are not financial advisors and the content is not intended to provide advice or recommendations for any security, investment product or any other product or service mentioned on this Blog. You should not use this Blog to make financial decisions and you should instead seek advice from professionals who are authorized to provide investment advice. Although best efforts have been taken to keep the information on this Blog accurate, this Blog may contain errors and inaccuracies. You alone assume the sole responsibility of the risks associated with the use of any content on the Blog. In no event shall any of the content creators be liable for any damages in connection with the information contained in this Blog or links provided.
Disclosure: I (username Adastra) am an investor not a trader. I am bullish on the Cannabis sector as a long-term investment (2026 and beyond), provided stocks/ETFs are carefully picked based on data-driven due diligence. Of the 16 stocks covered in the Best Cannabis Stocks analysis, I have invested only in my top 3 picks: High Tide, Green Thumb and Curaleaf. But my analysis indicates (without any guarantees) that there is a potential for impressive gains in investing in the stocks best ranked in the analysis, including WM Technology, and Trulieve, which have a dedicated page with detailed analysis in the STOCKS category. I reserve the right to buy or sell at any time any of the stocks mentioned in this blog. I do not short stocks and never will short any stock in a company that makes the world a better place. I do not have insider knowledge of any company covered in this blog. All data used for analysis is from public sources. I have received (as of last update date of this page) ZERO funding for this blog from any of the companies featured in this blog.